INSIGHTS ON CLINICAL TRIAL DESIGN
-
Why Should Site Agility Be Your Next Competitive Advantage?
Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.
-
Mergers And Acquisitions: How Institutional Knowledge Protecting Value
M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.
-
Why Clinical Trial Demographics Don't Match Real-World Populations
Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.
-
DCTs And Community-Based Research Execution And Compliance
The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
-
Improving The Patient Experience In Clinical Research2/6/2025
To preserve the quality of care and build a more effective approach to trial design, a sponsor must consider their approach to patient recruitment and enrollment early and often.
-
Understanding The FDA's Push For More Representation In Clinical Trials1/28/2025
Take action to improve diversity in clinical trials by addressing underrepresentation and ensuring equitable access to medical interventions, as emphasized by the FDA’s new 2025 guidance.
-
The Perfect Solution For Recruitment, Retention, And ROI8/15/2024
See how Citeline Connect was deployed to advance enrollment six months ahead of schedule for a sponsor’s Phase IV atopic dermatitis trial and build a community of engaged patients.
-
Rapid Expansion Of Peptide And Nanobody Drug Conjugates7/21/2026
Peptide and nanobody drug conjugates are gaining momentum, with 106 active programs identified globally. Learn more about the fast-evolving space for targeted drug delivery and competitive opportunities.
-
How The Right Meetings Make Patient-Centered Trial Design Possible7/30/2025
Including patients in trial design improves recruitment, retention, and site experience. Explore practical ways sponsors can gather early input—without disrupting timelines or adding complexity.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Accelerate obesity research with specialized expertise in GLP-1 trials. Our approach ensures rapid enrollment, high participant retention, and clean data through a patient-centered model.
-
Explore an expertly crafted package of programs, products, and expertise addressing the unique challenges of vaccine research.
-
Patient retention has benefits beyond what’s reflected in a data set. Explore some of the ways clinical trial participation can have a transformative impact on patients and their families.
-
Advarra University is the main hub for all of the training opportunities to help your team and staff feel confident in navigating the technology in their day-to-day operations.
-
CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.